# Canchalagua (Schkuhria pinnata)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/canchalagua
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-31
**Evidence Score:** 2 / 10
**Category:** Amazonian
**Also Known As:** Schkuhria pinnata, Andean canchalagua, Pinnateleaf falsegoldenaster, Canchalagua herb, Andean diabetes herb

## Overview

Canchalagua (Schkuhria pinnata) is an Amazonian medicinal herb whose flavonoid and terpenoid constituents drive its antidiabetic activity by enhancing insulin receptor expression and stimulating glucose uptake in peripheral tissues. Preclinical evidence supports its traditional use for blood sugar regulation through direct modulation of insulin signaling pathways.

## Health Benefits

• Stimulates glucose uptake and enhances insulin receptor expression, as seen in preclinical studies (PMID 37598765).
• Exhibits [anti-inflammatory](/ingredients/condition/inflammation) effects by inhibiting TNF-α and ASK1, based on cell model research.
• Demonstrates hypoglycemic activity in vivo, supporting traditional antidiabetic uses.
• Shows antiproliferative effects against cancer cells through ROS production and [mitochondrial](/ingredients/condition/energy) disruption.
• Provides antiprotozoal activity, as indicated by sesquiterpene lactone studies.

## Mechanism of Action

Schkuhria pinnata bioactives upregulate insulin receptor expression on cell membranes, facilitating downstream glucose transporter (GLUT) activation and increased intracellular glucose uptake, as demonstrated in preclinical cell models (PMID 37598765). The herb simultaneously suppresses apoptosis signal-regulating kinase 1 (ASK1) and reduces TNF-α secretion, attenuating the chronic low-grade inflammation that impairs [insulin sensitivity](/ingredients/condition/weight-management) in metabolic disease. These dual actions — pro-insulin signaling and [anti-inflammatory](/ingredients/condition/inflammation) — suggest a complementary mechanism relevant to type 2 diabetes pathophysiology.

## Clinical Summary

Current evidence for Schkuhria pinnata is limited to in vitro cell models and in vivo animal studies; no published randomized controlled trials in humans have been completed as of 2024. The in vivo hypoglycemic studies demonstrated measurable reductions in fasting [blood glucose](/ingredients/condition/weight-management) in rodent models, consistent with its traditional antidiabetic application across Amazonian and Andean ethnomedicine. Cell-based research (PMID 37598765) quantified improvements in insulin receptor expression and glucose uptake under controlled conditions, providing a plausible mechanistic rationale. The overall evidence base is preliminary, and clinical efficacy and optimal dosing in humans remain to be established.

## Nutritional Profile

Canchalagua (Schkuhria pinnata) is a medicinal herb rather than a staple food, so macronutrient content is not a primary focus; however, available phytochemical and partial nutritional data indicate the following: Bioactive compounds dominate its profile, including flavonoids (quercetin, kaempferol, and their glycosides estimated at 1.2–3.8% dry weight), sesquiterpene lactones (notably schkuhrin I and II, thiophene derivatives at approximately 0.5–1.5% dry weight), and phenolic acids (chlorogenic acid, caffeic acid at trace to 0.8% dry weight). Alkaloid content is minimal but present. Crude fiber content is moderate, estimated at 15–25% dry weight based on comparable Asteraceae family members. Protein content is low, approximately 8–12% dry weight, with limited bioavailability due to plant cell wall binding. Mineral content includes detectable levels of potassium, calcium, and magnesium (exact concentrations not well-characterized in published literature; comparative Asteraceae data suggests potassium 200–400 mg/100g dry weight, calcium 100–250 mg/100g dry weight). Vitamin content is not well-documented, though small amounts of vitamin C and beta-carotene are plausible given its leaf-dominant use. Essential oils contain alpha-pinene and limonene at trace levels. Bioavailability note: The thiophene derivatives and sesquiterpene lactones are lipophilic and may have enhanced absorption with fatty food co-ingestion; flavonoid glycosides require [gut microbiome](/ingredients/condition/gut-health) hydrolysis for activation. Most concentration data is extrapolated from related Schkuhria species and general Asteraceae phytochemistry due to limited direct assay studies on this specific species.

## Dosage & Preparation

Preclinical studies utilized various extracts, including aqueous freeze-dried and butanone/pentane extracts, but specific dosages for humans are not established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

No formal human safety trials have been conducted for Schkuhria pinnata, and its toxicological profile in humans is not yet well characterized. Because of its documented hypoglycemic activity in preclinical models, concurrent use with insulin, metformin, or other antidiabetic medications carries a theoretical risk of additive [blood glucose](/ingredients/condition/weight-management) lowering and hypoglycemia. Pregnant and breastfeeding individuals should avoid this herb due to insufficient safety data. Individuals with autoimmune conditions or those taking [immunomodulatory](/ingredients/condition/immune-support) drugs should exercise caution given the herb's TNF-α inhibitory activity.

## Scientific Research

No human clinical trials or meta-analyses were available for Schkuhria pinnata. Existing evidence is limited to preclinical studies focusing on its glucose uptake and [anti-inflammatory](/ingredients/condition/inflammation) properties (PMID 37598765).

## Historical & Cultural Context

Traditionally used in Andean medicine for treating infections, [inflammation](/ingredients/condition/inflammation), skin pathologies, and diabetes, Canchalagua's historical use aligns with its observed antidiabetic effects in modern studies.

## Synergistic Combinations

Berberine, Curcumin, Quercetin, Resveratrol, Alpha-Lipoic Acid

## Frequently Asked Questions

### How does canchalagua lower blood sugar?

Canchalagua (Schkuhria pinnata) lowers blood sugar primarily by upregulating insulin receptor expression on target cells, which enhances the cell's sensitivity to circulating insulin and promotes greater glucose uptake via GLUT transporters. It also suppresses TNF-α, a cytokine that directly impairs insulin receptor signaling, thereby reducing inflammation-driven insulin resistance. These mechanisms have been demonstrated in preclinical cell and animal models (PMID 37598765).

### Is canchalagua safe to take with diabetes medication?

Combining canchalagua with antidiabetic drugs such as metformin, sulfonylureas, or insulin poses a theoretical risk of additive hypoglycemia due to its demonstrated blood glucose-lowering effects in animal models. No human pharmacokinetic or drug interaction studies have been published, so the magnitude of this interaction is unknown. Anyone managing diabetes with medication should consult a healthcare provider before adding canchalagua to their regimen.

### What is the traditional use of canchalagua (Schkuhria pinnata)?

In Amazonian and Andean traditional medicine, Schkuhria pinnata has been used for generations as a remedy for diabetes and elevated blood sugar, typically prepared as a decoction or tea from the aerial parts of the plant. It has also been applied traditionally to manage fever and inflammation. Modern preclinical research has begun to validate the antidiabetic rationale through identification of molecular mechanisms involving insulin receptor upregulation and TNF-α suppression.

### What compounds in canchalagua are responsible for its effects?

The primary bioactive constituents of Schkuhria pinnata are believed to include flavonoids and terpenoids, classes of phytochemicals commonly associated with antioxidant, anti-inflammatory, and insulin-sensitizing activity. These compounds are thought to interact with ASK1 (apoptosis signal-regulating kinase 1) and TNF-α signaling nodes to reduce inflammatory stress on metabolic tissues. Precise isolation and characterization of the single most active molecule have not yet been fully established in published literature.

### Are there any human clinical trials on canchalagua?

As of 2024, no published randomized controlled trials or formal phase I/II clinical studies in human subjects have been completed for Schkuhria pinnata. Available evidence consists of in vitro cell model data and in vivo rodent studies demonstrating hypoglycemic and anti-inflammatory effects. While these findings are mechanistically promising, the absence of human trial data means that effective dosages, bioavailability, and clinical safety in people remain undetermined.

### What is the most effective form or preparation of canchalagua?

Canchalagua is traditionally prepared as a decoction or herbal tea, which allows for extraction of its active compounds. Standardized extracts and capsules are also used in modern supplements, though research directly comparing bioavailability across different preparation methods is limited. The traditional water-based preparation may offer advantages for solubility of certain phytochemicals, but clinical evidence supporting one form over another is not yet established.

### Is canchalagua safe to take during pregnancy or while breastfeeding?

Safety data for canchalagua in pregnant or breastfeeding women is not available from clinical trials, making it prudent to avoid use during these periods. Traditional use in some South American cultures does not constitute modern safety evidence for pregnancy and lactation. Women who are pregnant or breastfeeding should consult a healthcare provider before using canchalagua supplements.

### How strong is the scientific evidence supporting canchalagua's blood sugar benefits?

Current evidence is primarily based on preclinical studies and animal models demonstrating glucose uptake stimulation and insulin receptor enhancement, with limited human clinical data available. While traditional use in Andean medicine supports antidiabetic applications, robust randomized controlled trials in human populations are lacking. More rigorous clinical research is needed to establish efficacy and appropriate dosing for blood sugar management in humans.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*